Celgene Promotes Smith to President, Fouse to Retire

Xconomy New York — 

Summit, NJ-based Celgene (NASDAQ: CELG) said that president and chief operating officer Jacqualyn Fouse will retire and be replaced by Scott Smith, who currently runs the company’s inflammation and immunology franchise. Smith will take on his new role on April 1, when Fouse will transition to being a strategic adviser. She will officially retire from Celgene on June 30.